AI English summary of an SEC filing — figures as filed
IQVIA said it reported Q4 2024 revenue of $3,958 million and GAAP Net Income of $437 million, and full-year revenue of $15,405 million and GAAP Net Income of $1,373 million. GAAP Net Income for Q4 fell 6.8% from a year earlier, while full-year GAAP Net Income rose 1.1% from the prior year.
Key points
AI summaryIQVIA said it reported Q4 2024 revenue of $3,958 million and GAAP Net Income of $437 million, and full-year revenue of $15,405 million and GAAP Net Income of $1,373 million. GAAP Net Income for Q4 fell 6.8% from a year earlier, while full-year GAAP Net Income rose 1.1% from the prior year.
IQVIA said R&DS contracted backlog, including reimbursed expenses, was $31.1 billion as of December 31, 2024, up 4.4% year-over-year (5.5% at constant currency). The company said about $7.9 billion of this backlog is expected to convert to revenue in the next 12 months. It also said the Q4 book-to-bill ratio was 1.20x.
IQVIA said full-year 2024 Operating Cash Flow was $2,716 million, up from $2,149 million a year earlier. It said Free Cash Flow was $2,114 million, after deducting $602 million for acquisition of property, equipment and software.
IQVIA said it repurchased $1,150 million of its shares in Q4 2024 and $1,350 million for the full year. It also reaffirmed its full-year 2025 revenue outlook of $15,725 million to $16,125 million.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q4 2024 and Full-Year Revenue and GAAP Net Income
IQVIA said it reported Q4 2024 revenue of $3,958 million and GAAP Net Income of $437 million, and full-year revenue of $15,405 million and GAAP Net Income of $1,373 million. GAAP Net Income for Q4 fell 6.8% from a year earlier, while full-year GAAP Net Income rose 1.1% from the prior year.
Source · Based on the filing body and exhibits
R&DS Contracted Backlog and Book-to-Bill Ratio
IQVIA said R&DS contracted backlog, including reimbursed expenses, was $31.1 billion as of December 31, 2024, up 4.4% year-over-year (5.5% at constant currency). The company said about $7.9 billion of this backlog is expected to convert to revenue in the next 12 months. It also said the Q4 book-to-bill ratio was 1.20x.
Source · Based on the filing body and exhibits
Full-Year 2024 Operating Cash Flow and Free Cash Flow
IQVIA said full-year 2024 Operating Cash Flow was $2,716 million, up from $2,149 million a year earlier. It said Free Cash Flow was $2,114 million, after deducting $602 million for acquisition of property, equipment and software.
Source · Based on the filing body and exhibits
Share Repurchases and Full-Year 2025 Revenue Outlook
IQVIA said it repurchased $1,150 million of its shares in Q4 2024 and $1,350 million for the full year. It also reaffirmed its full-year 2025 revenue outlook of $15,725 million to $16,125 million.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…